Researchers from the UCLA Health Jonsson Comprehensive Cancer Center have demonstrated in a recent study that their novel non ...
A recent study conducted by UCLA Health Jonsson Comprehensive Cancer Center researchers found that new, non-invasive imaging ...
A recent study conducted by UCLA Health Jonsson Comprehensive Cancer Center researchers found that new, non-invasive imaging ...
UCLA researchers developed a non-invasive imaging method using 89Zr-TLX250 to detect clear-cell renal cell carcinoma. This ...
Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the first patient has been dosed in a Phase ...
UCLA Health researchers unveiled a novel non-invasive imaging technique that accurately detects clear-cell renal cell ...
US clinical-stage biotech Arcus Biosciences has entered into a clinical trial collaboration with AstraZeneca on renal cancer ...
No benefit seen for rechallenge with nivolumab after progression in the post-immune checkpoint inhibitor setting.
Arcus Biosciences has announced a clinical trial partnership with AstraZeneca to assess casdatifan plus volrustomig for renal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback